In many cases, conventional treatments for localised breast cancer do not prevent the development of metastatic disease. Recent developments in the treatment of metastatic breast cancer include monoclonal antibody therapies that work by targeting specific growth factors found in abnormally high numbers in some patients. Within the UK, the treatment is set to become more widely used in the near future for the management of metastatic breast cancer.
Cancer Nursing Practice. 1, 1, 22-25. doi: 10.7748/cnp2002.02.1.1.22.c5
Keywords :
or
Alternatively, you can purchase access to this article for the next seven days. Buy now
Are you a student? Our student subscription has content especially for you.
Find out more
